CULVER CITY, Calif.–(BUSINESS WIRE)–Jun. 7, 2016– NantHealth, Inc. (formerly known as Nant Health, LLC), a next-generation, evidence-based, personalized healthcare company, announced today the closing of its initial public offering of 6,500,000 shares of its common stock at a price to the public of $14.00 per share (which reflects a 1-for-5.5 reverse stock split of NantHealth’s common stock effected in connection with the conversion of the company from a limited liability company to a corporation). In addition, NantHealth has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares of its common stock, at the public offering price, less underwriting discounts and commissions.
Jefferies LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering, and First Analysis Securities Corporation, Canaccord Genuity Inc., and FBR Capital Markets & Co. are acting as co-managers.
A copy of the final prospectus related to the offering may be obtained from: Jefferies LLC, Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, or by telephone at (877) 547-6340 or by email at [email protected]; or Cowen and Company, LLC, c/o Broadridge Financial Services, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (631) 274-2806 or by fax at (631) 254-7140.
A registration statement relating to these securities has been declared effective by the Securities and Exchange Commission on June 1, 2016. This offering was made only by means of a prospectus. Copies of the registration statement, as amended, can be accessed through the SEC’s website at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.